Authors:
Bjoro, K
Kirkegaard, P
Ericzon, BG
Friman, S
Schrumpf, E
Isoniemi, H
Herlenius, G
Olausson, M
Rasmussen, A
Foss, A
Hockerstedt, K
Citation: K. Bjoro et al., Is a 3-day limit for highly urgent liver transplantation for fulminant hepatic failure appropriate, and is the diagnosis in some cases incorrect?, TRANSPLAN P, 33(4), 2001, pp. 2511-2513
Authors:
Bjoro, K
Petrova, EP
Thomas, MG
Froland, SS
Williams, R
Naoumov, NV
Citation: K. Bjoro et al., TT virus infection in patients with primary hypogammaglobulinaemia: Natural history and relationship to liver disease in the immunocompromised host, SC J GASTR, 36(9), 2001, pp. 987-993
Citation: K. Bjoro et al., Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia, QJM-MON J A, 92(8), 1999, pp. 433-441
Authors:
Bjoro, K
Friman, S
Hockerstedt, K
Kirkegaard, P
Keiding, S
Schrumpf, E
Olausson, M
Oksanen, A
Isoniemi, H
Hjortrup, A
Bergan, A
Ericzon, BG
Citation: K. Bjoro et al., Liver transplantations in the Nordic countries, 1982-1998: Changes of indications and improving results, SC J GASTR, 34(7), 1999, pp. 714-722
Authors:
Bell, H
Hellum, K
Harthug, S
Myrvang, B
Ritland, S
Maeland, A
von der Lippe, B
Bjoro, K
Skaug, K
Gutigard, BG
Raknerud, N
Simmonds, P
Citation: H. Bell et al., Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a, SC J GASTR, 34(2), 1999, pp. 194-198
Authors:
Bjoro, K
Schrumpf, E
Bergan, A
Haaland, T
Skaug, K
Froland, SS
Citation: K. Bjoro et al., Liver transplantation for endstage hepatitis C cirrhosis in a patient withprimary hypogammaglobulinaemia, SC J IN DIS, 30(5), 1998, pp. 520-522